Nature cell biology
Cure8 research brief
Monocyte surface Y RNAs potentiate innate immunity.
Research and clinical trials
Basic Science
Researchers
Clinicians
Adult patients
Inflammatory bowel disease
Why This Matters
The study identifies a new monocyte-surface RNA (Y RNAs) that appears higher in an exploratory IBD cohort and amplifies inflammatory signalling in cells and mice, which could point to new biomarker or therapeutic directions for IBD.
Who Should Pay Attention
Researchers (immunology, biomarker discovery), translational clinicians, and IBD-interested scientists.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This Nature Cell Biology abstract reports that Y RNAs localize to human monocyte surfaces, where they bind extracellular histones and co-cluster with TLR2/TLR4 to amplify NF-κB/AP-1 signalling and increase IL‑6 production.
The authors observed more Y-RNA–positive monocytes in an exploratory IBD patient group versus healthy donors or IBS controls, and showed that in vivo depletion of cell-surface Y RNAs lessened disease activity in a mouse colitis model. The work is basic-science: mechanistic cell and mouse experiments plus an exploratory human cohort.
The abstract supports the biological model but does not provide clinical outcomes data or therapeutic guidance for patients. Further validation in larger human studies and safety assessment would be needed before clinical translation.
Keep In Mind
Findings are from a journal abstract describing mechanistic cell and mouse experiments plus an exploratory human cohort; results are preclinical and need further validation before clinical application.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationNature cell biology
AuthorsXiao Jiang, Weizhi He, Chu Xu +16 more
InstitutionCancer Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Key Laboratory of Medical Epigenetics, International Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedOct 19, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Competing interests: Patents have been filed by Fudan University Shanghai Cancer Center and Sycamore Research Institute of Life Sciences, Shanghai. The authors declare no competing interests.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
NEAT1 modulates neutrophil functions via glycolysis to restrain mucosal inflammation in ulcerative colitis
The study links NEAT1, a long noncoding RNA, to neutrophil-driven mucosal inflammation in ulcerative colitis and suggests NEAT1 affects neutrophil activity via glycolysis. That points to a new molecular pathway that...
MXRA7: A potential link between macrophage M1 polarization and epithelial Pyroptosis in ulcerative colitis.
The paper suggests a specific molecule, MXRA7, links macrophage M1 polarization and epithelial pyroptosis—two processes implicated in ulcerative colitis tissue damage. If validated, this could point to new targets for...
β-Glucan alleviates colitis by remodeling the colonic microenvironment and promoting interleukin-33-driven active eosinophil differentiation.
The study identifies a β-glucan → IL-33 → active eosinophil pathway that reduced colitis in a mouse model, suggesting a novel immunomodulatory mechanism that could inform future IBD research.